CARYN SHAHIN: Open Payments
NPI 1518584424 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 14 payments from 6 companies in 2025. Trend: 2023 $238 · 2024 $441 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $175 |
| E.R. Squibb & Sons, L.L.C. | 3 | $135 |
| Neurocrine BioSciences, Inc. | 4 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $60 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: ARISTADA, COBENFY, INGREZZA, CAPLYTA, UZEDY, ABILIFY ASIMTUFII.
Industry payments across AZ — which companies pay providers there.
